MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 11-08-2023
Country |
 USA |
IPO year |
2015 |
Industry |
Diagnostics research |
Stock Exchange |
NYSESPB |
Shares |
236 M |
Market Cap[1] |
$ 21.2 M |
EBITDA (LTM) |
$ -1.62 B |
P/E (LTM) |
- |
P/S (LTM) |
0.04 |
EPS (LTM) |
-6.24 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Anixa Biosciences
ANIX
|
$ 2.6 | 1.96 % | $ 84.4 K | Nasdaq Capital Market | USA |
 |
Agilent Technologies
A
|
$ 114.87 | -0.53 % | $ 34.9 B | NYSE,SPB | USA |
|
Biodesix
BDSX
|
$ 15.17 | 0.66 % | $ 1.97 B | Nasdaq Global Market | USA |
 |
Biomerica
BMRA
|
$ 2.15 | -0.69 % | $ 4.94 M | Nasdaq Capital Market | USA |
 |
BioNano Genomics
BNGO
|
$ 1.16 | -3.33 % | $ 6.32 M | Nasdaq Capital Market,SPB | USA |
 |
Burning Rock Biotech Limited
BNR
|
$ 17.06 | 5.31 % | $ 179 M | Nasdaq Global Market |  China |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
CareDx, Inc
CDNA
|
$ 18.31 | - | $ 976 M | Nasdaq Global Market,SPB | USA |
 |
Celcuity
CELC
|
$ 114.35 | 1.53 % | $ 5.35 B | Nasdaq Global Select Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Co-Diagnostics
CODX
|
$ 4.4 | 101.83 % | $ 5.85 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Charles River Laboratories International
CRL
|
$ 169.1 | -2.75 % | $ 8.38 B | NYSE,SPB | USA |
 |
Castle Biosciences
CSTL
|
$ 24.99 | 0.58 % | $ 694 M | Nasdaq Global Market,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 192.41 | 0.67 % | $ 137 B | NYSE,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
DexCom
DXCM
|
$ 63.07 | 1.36 % | $ 24.6 B | Nasdaq Global Select Market,SPB | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Fulgent Genetics
FLGT
|
$ 16.69 | -0.77 % | $ 505 M | Nasdaq Global Market | USA |
 |
Guardant Health
GH
|
$ 90.5 | -3.55 % | $ 11.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 111.66 | -2.22 % | $ 9.21 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Interpace Biosciences
IDXG
|
$ 1.96 | 5.82 % | $ 8.67 M | Nasdaq Global Select Market | USA |
 |
Illumina
ILMN
|
$ 127.94 | 0.44 % | $ 20.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
IQVIA Holdings
IQV
|
$ 171.14 | -1.22 % | $ 29.4 B | NYSE,SPB | USA |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 275.68 | 0.72 % | $ 22.9 B | NYSE,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 75.7 | -0.53 % | $ 5.11 B | Nasdaq Global Select Market,SPB | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Medpace Holdings
MEDP
|
$ 492.38 | -1.2 % | $ 14.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 258.5 | -0.28 % | $ 25.9 B | NYSE,SPB |  Schweiz |
 |
Myriad Genetics
MYGN
|
$ 4.78 | 0.53 % | $ 443 M | Nasdaq Global Select Market,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 4.51 | -3.84 % | $ 3.55 M | Nasdaq Global Select Market | USA |
 |
NeoGenomics
NEO
|
$ 8.0 | -0.06 % | $ 1.02 B | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 9.49 | 0.8 % | $ 2.06 B | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 17.32 | 0.93 % | $ 388 M | Nasdaq Global Select Market | USA |
 |
Natera
NTRA
|
$ 205.17 | -1.35 % | $ 20.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Pacific Biosciences of California
PACB
|
$ 1.4 | 4.1 % | $ 420 M | Nasdaq Global Select Market,SPB | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 27.09 | -0.07 % | $ 20 B | NYSE |  Niderland |
 |
Precipio
PRPO
|
$ 24.93 | -2.46 % | $ 40 M | Nasdaq Global Select Market | USA |
 |
Personalis
PSNL
|
$ 6.7 | 1.82 % | $ 397 M | Nasdaq Global Select Market | USA |
 |
RadNet
RDNT
|
$ 55.07 | 0.5 % | $ 4.14 B | Nasdaq Global Select Market | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.